FindTrial
Sign In

Brain Imaging: Cocaine Effects & Medication Development - 5

Brain Imaging: Cocaine Effects & Medication Development

Status
Withdrawn
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00000270
Enrollment
0
Registered
1999-09-21
Start date
1995-12-30
Completion date
1995-12-30
Last updated
2017-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cocaine-Related Disorders

Keywords

cocaine

Brief summary

The purpose of this study is to define temporal profile of brain activation (rCBF) using Xenon-SPECT and O 15-PET.

Interventions

DRUGCocaine

Sponsors

National Institute on Drug Abuse (NIDA)
CollaboratorNIH
New York State Psychiatric Institute
Lead SponsorOTHER

Study design

Primary purpose
TREATMENT

Eligibility

Sex/Gender
ALL
Age
18 Years to 48 Years
Healthy volunteers
No

Inclusion criteria

Please contact site for information.

Design outcomes

Primary

MeasureTime frame
Absolute change in rCBF at 5 & 15 minutes (Xe)—
Relative change in rCBF at 5, 19, & 33 minutes (O15)—
Correlated with a) subjective effects, b) venous blood level of coca, c) autonomic variables—

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026